LFCR Lifecore Biomedical Inc

Price (delayed)

$7.51

Market cap

$278.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.48

Enterprise value

$402.05M

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for ...

Highlights
The company's quick ratio rose by 39% YoY and by 16% QoQ
LFCR's revenue is up by 7% YoY
Lifecore Biomedical's gross profit has increased by 35% YoY but it has decreased by 4.5% QoQ
The company's gross margin rose by 26% YoY but it fell by 4.3% QoQ
LFCR's EPS has shrunk by 196% QoQ and by 121% YoY
Lifecore Biomedical's net income has plunged by 121% YoY

Key stats

What are the main financial stats of LFCR
Market
Shares outstanding
37.03M
Market cap
$278.06M
Enterprise value
$402.05M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
124.75
Price to sales (P/S)
2.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.09
Earnings
Revenue
$130.31M
Gross profit
$43.59M
Operating income
-$20.42M
Net income
-$44.65M
EBIT
-$22.6M
EBITDA
-$14.23M
Free cash flow
-$3.87M
Per share
EPS
-$1.48
EPS diluted
-$1.45
Free cash flow per share
-$0.1
Book value per share
$0.06
Revenue per share
$3.52
TBVPS
$5.93
Balance sheet
Total assets
$237.69M
Total liabilities
$190.27M
Debt
$129.41M
Equity
$2.23M
Working capital
$53.1M
Liquidity
Debt to equity
58.06
Current ratio
2.71
Quick ratio
1.31
Net debt/EBITDA
-8.71
Margins
EBITDA margin
-10.9%
Gross margin
33.4%
Net margin
-34.3%
Operating margin
-15.7%
Efficiency
Return on assets
-19.9%
Return on equity
-788.6%
Return on invested capital
-7.1%
Return on capital employed
-10.9%
Return on sales
-17.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFCR stock price

How has the Lifecore Biomedical stock price performed over time
Intraday
-0.27%
1 week
-2.21%
1 month
-9.3%
1 year
30.16%
YTD
1.08%
QTD
-7.51%

Financial performance

How have Lifecore Biomedical's revenue and profit performed over time
Revenue
$130.31M
Gross profit
$43.59M
Operating income
-$20.42M
Net income
-$44.65M
Gross margin
33.4%
Net margin
-34.3%

LFCR financials

Lifecore Biomedical's net income has plunged by 121% YoY
Lifecore Biomedical's net margin has plunged by 107% YoY
LFCR's operating margin has plunged by 67% from the previous quarter and by 8% YoY
The company's operating income has shrunk by 66% QoQ and by 16% YoY

Price vs fundamentals

How does LFCR's price correlate with its fundamentals

LFCR Price vs fundamentals

LFCR Earnings waterfall

LFCR Price vs fair value

Growth

What is Lifecore Biomedical's growth rate over time

LFCR growth chart

Valuation

What is Lifecore Biomedical stock price valuation
P/E
N/A
P/B
124.75
P/S
2.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.09

Valuation vs average

Price to earnings (P/E)

LFCR's EPS has shrunk by 196% QoQ and by 121% YoY

Price to book (P/B)

LFCR's equity has dropped by 87% year-on-year and by 86% since the previous quarter

Price to sales (P/S)

The price to sales (P/S) is 34% higher than the last 4 quarters average of 1.6 but 14% lower than the 5-year quarterly average of 2.5
LFCR's revenue is up by 7% YoY

Efficiency

How efficient is Lifecore Biomedical business performance
The ROA has plunged by 146% YoY
Lifecore Biomedical's ROE has soared by 87% YoY

Dividends

What is LFCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFCR.

Financial health

How did Lifecore Biomedical financials performed over time

Assets vs liabilities

LFCR's total assets is 25% more than its total liabilities
The company's quick ratio rose by 39% YoY and by 16% QoQ
The company's current ratio rose by 31% YoY and by 17% QoQ

Debt vs equity

LFCR's equity has dropped by 87% year-on-year and by 86% since the previous quarter
Lifecore Biomedical's debt has increased by 2.5% YoY

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.